Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) — Miami, Florida

Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) has participated in 1 clinical trials.

Therapeutic areas: High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Miami Cancer Institute at Baptist Health, Inc. ( Site 0110)?

Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) conducted?

Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) has 1 clinical trials on record. Their work covers High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma.

Is Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) accredited by Crixeo Health?

Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Miami Cancer Institute at Baptist Health, Inc. ( Site 0110)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.